Duncker Streett & Co’s St Jude Medical STJ Stock Holding History

Duncker Streett & Co’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-400	Closed	-$26K	–	631
2014 Q4	$26K	Hold	400	–	–	0.01%	450
2014 Q3	$24K	Hold	400	–	–	0.01%	455
2014 Q2	$28K	Hold	400	–	–	0.01%	442
2014 Q1	$26K	Hold	400	–	–	0.01%	436
2013 Q4	$25K	Hold	400	–	–	0.01%	425
2013 Q3	$21K	Hold	400	–	–	0.01%	421
2013 Q2	$18K	Buy	+400	New	+$17.3K	0.01%	437

Other funds holding STJ

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Duncker Streett & Co's STJ Position: Q1 2015 in Review

Duncker Streett & Co sold out of St Jude Medical (STJ) in Q1 2015, closing a stake of 400 shares — an estimated $26K sold.

Duncker Streett & Co first reported a position in STJ in Q2 2013 and held it in 7 quarters. The position peaked at $28K in Q2 2014. 590 funds tracked by Wall St. Rank hold STJ as of Q1 2015.

Duncker Streett & Co reported no remaining St Jude Medical position as of Q1 2015 after selling out during the quarter.
Duncker Streett & Co sold 400 St Jude Medical shares in Q1 2015, an estimated $26K.
Duncker Streett & Co first reported a position in St Jude Medical in Q2 2013 and held it in 7 quarters.
Duncker Streett & Co's St Jude Medical position peaked at $28K in Q2 2014.
590 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2015.

Based on Duncker Streett & Co's 13F filing for Q1 2015, filed 28 Apr 2015.